C07J 41/0027
Azides
Official title: {Azides}
C07J41/0027 (Azides) appears on 53 US grants and 21 published applications in this corpus.
Search patents in C07J- Granted patents
- 53
- Published applications
- 21
- Assignees
- 36
- Inventors
- 99
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 5 | 0 |
| 1997 | 7 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 2 |
| 2015 | 1 | 0 |
| 2016 | 1 | 2 |
| 2017 | 1 | 1 |
| 2018 | 2 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 1 | 4 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Small molecule modulators of gut bacterial bile acid metabolism17 Mar 2026US 12,577,273 B2President and Fellows of Harvard College
- Cyclin-dependent kinase degraders and methods of use10 Jun 2025US 12,325,725 B2Dana-Farber Cancer Institute, Inc.
- Ship inhibitors and uses thereof3 May 2022US 11,319,336 B2The Research Foundation for The State University of New York
- Reagent for extracting and amplifying nucleic acid28 Dec 2021US 11,208,686 B2Tosoh Corporation
- Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using11 Feb 2020US 10,556,873 B2Illinois Institute of Technology
- Cyclin-dependent kinase degraders and methods of use28 Aug 2025US 2025/0270252 A1Dana-Farber Cancer Institute, Inc.
- Pharmaceutical composition having anti-cancer immunostimulating effect and/or immune checkpoint inhibition potentiating effect2 Jan 2025US 2025/0002526 A1Keio University
- Cyclin-dependent kinase inhibitors and methods of use16 Nov 2023US 2023/0365620 A1Dana-Farber Cancer Institute, Inc.
- Small molecule modulators of gut bacterial bile acid metabolism30 Jun 2022US 2022/0204548 A1President and Fellows of Harvard College
- Compounds for targeted therapies of castration resistant prostate cancer2 Jun 2022US 2022/0169672 A1
Most cited
By later US patents
- vitamin D.sub.3 derivatives having a substituent at 2-position96US 4,666,634 AChugai Seiyaku Kabushiki Kaisha · 1987
- Pharmaceutical compositions and methods of transporting compounds across biological membrane93US 5,455,335 AThe Trustees of Princeton University · 1995
- Methods for controlling ocular hypertension with angiostatic steroids86US 4,876,250 AAlcon Laboratories, Inc. · 1989
- Angiostatic steroids and methods and compositions for controlling ocular hypertension78US 5,371,078 AAlcon Laboratories, Inc. · 1994
- Use of angiostatic steroids in photodynamic therapy75US 6,297,228 B1Alcon Manufacturing, Ltd. · 2001